Navigation Links
Amarin Reports Top-Line Results of two Phase III Studies of,Miraxion in Huntington's Disease

Miraxion in treating CNS disorders and specifically our next steps with respect to the HD trials. We also intend to progress the development of our novel, oral formulation of apomorphine to treat the 'off' episodes in advanced Parkinson's disease patients, our recently in-licensed nasal formulation of lorazepam for the out-patient treatment of emergency seizures in epilepsy patients and our proprietary combinatorial lipid pre-clinical program in CNS disorders and other indications." concluded Mr Stewart.

Thomas Lynch, Amarin's Chairman, added "Our commitment to neurology research and product development remains steadfast and we will continue to pursue other in-licensing opportunities while we advance our broad pipeline of products to treat CNS disorders. Amarin has in place an experienced and committed management team and a strong financial position with approximately $29 million in cash at the end of March 2007."

The first study, TREND-HD, was conducted in 42 sites in the U.S. and Canada by the Huntington Study Group (HSG) based at the University of Rochester Medical School in Rochester, N.Y. This study, led by Principal Investigator Prof. Ira Shoulson, enrolled 316 patients with HD. The TREND-EU Phase III study was conducted in 27 sites in six countries across Europe and was conducted in conjunction with the European HD Network. This study was led by Principal Investigator Prof. Bernhard Landwehrmeyer, and enrolled 290 patients with HD.

These trials were developed under a Special Protocol Assessment (SPA) agreed with the U.S. Food and Drug Administration (FDA) and Miraxion for HD has Fast Track designation by the FDA and Orphan Drug designation in both the U.S. and in Europe.

Conference Call

Amarin management will host a conference call to discuss the clinical results from the two Phase III trials today beginning at 11:00 a.m. Eastern time. To participate in the call, please dial (800) 968-7995 from the U.S. or (706) 679-8403 fr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:12/16/2009)... NEW YORK, December 16 ... the publication of GFT505 (80 mg/day),data ... 50 internationally,recognized expert scientists and clinicians ... the continuing role of generic lipid-modifying,treatments, ... which is commonly observed in patients ...
(Date:12/16/2009)... -- Verathon®, maker of BladderScan® bladder volume ... bladder volume ultrasound is now included in ... Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs). ... early November 2009, replace the previous guidelines ... guidelines are located on the Web at: ...
(Date:12/16/2009)... -- Greenway Medical Technologies, Inc. today announced that ... practice management and interoperability solution, Prime Suite® ... the annual 2009 Top 20 Best in ... report. ,, For practices having between six and ... Best in KLAS in ambulatory EMR for the ...
Breaking Medicine Technology:International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 2New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 4New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 5Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 2Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 3Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 4Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 1Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 2Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 3Study shows promise for new cancer stopping therapy 48649 1Study shows promise for new cancer stopping therapy 48649 2Study finds segregation decreases access to surgical care for minorities 48646 1Study finds segregation decreases access to surgical care for minorities 48646 2
... oil may improve gum health, ROCKPORT, Maine, ... working with dentists and their patients to study ... to inflammation and gum health., (Photo: ... Dental Association, 75% of all Americans will,develop some ...
... 12 Micromet, Inc.,(Nasdaq: MITI ), a ... of cancer, inflammation and autoimmune,diseases, today announced the ... new class of antibodies that recruit T cells" ... are designed to activate,the body,s T cells to ...
Other Medicine Technology:Maine Natural Health Company Conducts Dental Clinical Trial 2Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future 2Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future 3Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future 4Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future 5
(Date:12/17/2009)... one-in-three American adults who serve as a family caregiver , ... ... Alliance on Mental Illness (NAMI) praises a new report, Caregiving ... the nearly one-in-three American adults who serve as a family caregiver. ... chosen at random and offers a national profile of people caring ...
(Date:12/17/2009)... natural relief prior to considering drugs. , ... ... D-Psoria products are the first topical, non-prescription cosmeceuticals ... skin conditions . Developed by Astrel Genome Ltd., D-Psoria ... Pharmaceuticals, St. Louis, Missouri., , ,D-Psoria products were developed in ...
(Date:12/17/2009)... provide Baptist with on-going Healthcare Cost/Risk Analysis reports, activity measures ... improvements as it translates toward reduced claim costs and positive ... , ... Jacksonville, FL (PRWEB) ... risk management company specializing in clinical/claims based cost risk analysis ...
(Date:12/17/2009)... Children’s Hospital from nearby hot tub company helps raise money ... ... Salt Lake City, UT (PRWEB) December ... the donation of a Bullfrog Spa to aid in fund ... City, Utah. Primary Children’s Medical Center, serving child patients from ...
(Date:12/16/2009)... AUSTIN, Texas, Dec. 16 Austin,s Custom ... eco-friendly countertops, co-sponsored, with Ryan Gray and Hill Country ... 219 West on Wednesday, December 9th. Fifty people showed ... ate their way through platefuls of sliders in support ... ,, What started as a casual bet over who ...
Breaking Medicine News(10 mins):Health News:NAMI Applauds New Report on Caregiving 2Health News:NAMI Applauds New Report on Caregiving 3Health News:Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin 2Health News:Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin 3Health News:Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin 4Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:Bullfrog Spas Helps Critically Ill Children 2Health News:Bullfrog Spas Helps Critically Ill Children 3Health News:Bullfrog Spas Helps Critically Ill Children 4Health News:Austin-Based Business Co-Sponsors Gastric Feat for Charity 2
... and Drug Administration (FDA) approves new cancer fighting drugs ... non-approved, or off-label, treatments. When the studies show promise ... these drugs to patients. By some estimates, nearly 20 ... are for off-label use. Oncologists prescribe cancer drugs off-label ...
... be Driven by Drugs from Eli Lilly/Daiichi Sankyo, AstraZeneca, ... ResourcesWALTHAM, Mass., March 24 Decision Resources, one of ... and healthcare issues, finds that, despite the patent expiries ... launches will drive an increase of $4.6 billion in ...
... average selling prices to be affected into 2010, ... According to Millennium Research Group,s (MRG,s) US ... arthroplasty implants (shoulder, elbow, digit, ankle, and wrist) ... double-digit market growth seen in recent years will ...
... Pharmaceuticals, a privately held, specialty pharmaceutical company which ... the launch of Scalacort(TM) DK (defence kit), that ... kit.Scalacort DK includes Scalacort (hydrocortisone lotion USP) 2%, ... base. Scalacort relieves itching and inflammation of the ...
... HILLS, Calif., March 24 Regal International, Inc., ... ) has been appointed by EMK Products, LLC ... PLACENTAL(R) Skin Care Product line. Under the agreement, ... distributorship for the development and management of internet ...
... 24 The Arizona Attorney General,s Office has ... student-led nonprofit Live Action released videos with undercover ... The footage shows two Planned Parenthood clinics in ... disregarding mandatory reporting laws for sexual abuse, and ...
Other Medicine News:Health News:IROs Help Decide Medically on Approved Uses of Off-Label Drugs for Cancer 2Health News:IROs Help Decide Medically on Approved Uses of Off-Label Drugs for Cancer 3Health News:Despite Patent Expiries of Leading Therapies, New Product Launches Will Drive a $4.6 Billion Increase in the Coronary Heart Disease Market 2Health News:Job Loss Means Fewer Americans Have Health Care Coverage: How Will the Economic Downturn Affect the Small-Joint Implant Market? 2Health News:Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit 2Health News:Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit 3Health News:EMK Placental Appoints Beauty Beverly Hills for Exclusive Distributorship. 2Health News:EMK Placental Appoints Beauty Beverly Hills for Exclusive Distributorship. 3Health News:Arizona Attorney General to Investigate Sexual Abuse Cover Up at Planned Parenthood Clinics 2
... The Accommodating Intraocular Lens is for the treatment ... in many middle aged and older patients. , ... in the natural lens of the eye as ... less elastic. With less elasticity, the eye has ...
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
... patient, right for the not-so-typical patient. , ... the ability to address the atypical situations ... themeven after implant. St. Jude Medical ICDs ... prepared in almost any situation, from high ...
Medicine Products: